Furthermore, the IF analysis of CRC tissues revealed that a significant FSTL3 expression was shown by KRT19-positive cancer cells (Fig. 1C and Supplementary Fig. S1B). This evidence concerns the gene FSTL3 and colorectal carcinoma.